世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

eクリニカルソリューション市場（ソリューションタイプ：臨床試験管理システム、電子臨床結果評価、無作為化・治験薬供給管理、電子データ収集・臨床データ管理、電子試験マスターファイル、患者募集、規制情報管理システム、その他） - 世界の産業分析、規模、シェア、成長、動向、予測、2023年～2031年


eClinical Solutions Market (Solution Type: Clinical Trial Management Systems, Electronic Clinical Outcome Assessment, Randomization & Trial Supply Management, Electronic Data Capture & Clinical Data Management, Electronic Trial Master Files, Patient Recruitment, Regulatory Information Management System, Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

eクリニカルソリューション市場 - レポートの範囲 TMRの調査レポート「世界のeクリニカルソリューション市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけ... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Transparency Market Research
トランスペアレンシーマーケットリサーチ 		2023年8月24日 US$5,795
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		235 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

eクリニカルソリューション市場 - レポートの範囲
TMRの調査レポート「世界のeクリニカルソリューション市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界のeクリニカルソリューション市場の収益を提供しています。また、2023年から2031年までの世界のeクリニカルソリューション市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書を参照し、eClinicalソリューション市場を理解しました。

二次調査には、インターネットソース、政府機関の統計データ、ウェブサイト、業界団体なども含まれる。アナリストは、トップダウンアプローチとボトムアップアプローチを組み合わせて、世界のeクリニカルソリューション市場の様々な属性を調査した。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、世界のeClinicalソリューション市場における競争ダイナミクスの変化にも光を当てています。これらは、既存の市場プレイヤーだけでなく、世界のeClinicalソリューション市場への参入に関心のある企業にとっても貴重なツールとなります。

本レポートでは、世界のeクリニカルソリューション市場の競争環境について掘り下げています。世界のeClinicalソリューション市場で事業を展開する主要企業が特定され、これらの各企業が様々な属性の観点からプロファイリングされています。会社概要、財務状況、最近の動向、SWOTは、本レポートでプロファイリングされた世界のeClinicalソリューション市場のプレーヤーの属性です。

eクリニカルソリューションの世界市場レポートで回答された主な質問
- 予測期間中、全地域でeClinicalソリューションが生み出す売上/収益は？
- 世界のeClinicalソリューション市場におけるビジネスチャンスは？
- 市場の主な促進要因、阻害要因、機会、脅威は何か？
- 予測期間中に最も速いCAGRで拡大する地域市場はどこか？
- 2031年に世界で最も高い収益を上げると予測されるセグメントは？
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは？
- 世界市場で事業を展開する各企業の市場ポジションは？

eクリニカルソリューション市場 - 調査目的と調査アプローチ
eクリニカルソリューションの世界市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと販売業者、製品承認に関する規制シナリオについて詳しく解説しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフや表が適切に散りばめられた網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化し、読者に視覚的に訴える。また、過去と予測期間末の主要セグメントの市場シェアを比較することもできる。

本レポートでは、世界のeクリニカルソリューション市場を製品、エンドユーザー、地域の観点から分析している。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界のeClinicalソリューション市場への投資について、情報に基づいたビジネス上の意思決定を行うことができます。

ページTOPに戻る


目次

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global eClinical Solutions Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global eClinical Solutions Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
    5.1. Technological Advancements
    5.2. Regulatory Scenario, by Region
    5.3. Value Chain Analysis
    5.4. COVID-19 impact on the Industry
6. Global eClinical Solutions Market Analysis and Forecast, by Solution Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Solution Type, 2017-2031
        6.3.1. Clinical Trial Management Systems
        6.3.2. Electronic Clinical Outcome Assessment
        6.3.3. Randomization & Trial Supply Management
        6.3.4. Electronic Data Capture & Clinical Data Management
        6.3.5. Electronic Trial Master Files
        6.3.6. Patient Recruitment
        6.3.7. Regulatory Information Management Systems
        6.3.8. Others
    6.4. Market Attractiveness Analysis, by Solution Type
7. Global eClinical Solutions Market Analysis and Forecast, by Delivery Mode
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Delivery Mode, 2017-2031
        7.3.1. Licensed Enterprise/On-premise
        7.3.2. Web-based
        7.3.3. Others
        7.3.4. Cloud-based/Software-as-a-service (SaaS)
    7.4. Market Attractiveness Analysis, by Delivery Mode
8. Global eClinical Solutions Market Analysis and Forecasts, by Clinical Trial Phase
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        8.3.1. Phase I
        8.3.2. Phase II
        8.3.3. Phase III
        8.3.4. Phase IV
    8.4. Market Attractiveness Analysis, by Clinical Trial Phase
9. Global eClinical Solutions Market Analysis and Forecast, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by End-user, 2017-2031
        9.3.1. Pharmaceutical & Biotechnology Companies
        9.3.2. Medical Device Manufacturers
        9.3.3. Contract Research Organizations
        9.3.4. Others
    9.4. Market Attractiveness Analysis, by End-user
10. Global eClinical Solutions Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region, 2017-2031
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness By Country/Region
11. North America eClinical Solutions Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Solution Type, 2017-2031
        11.2.1. Clinical Trial Management Systems
        11.2.2. Electronic Clinical Outcome Assessment
        11.2.3. Randomization & Trial Supply Management
        11.2.4. Electronic Data Capture & Clinical Data Management
        11.2.5. Electronic Trial Master Files
        11.2.6. Patient Recruitment
        11.2.7. Regulatory Information Management Systems
        11.2.8. Others
    11.3. Market Value Forecast, by Delivery Mode, 2017-2031
        11.3.1. Licensed Enterprise/On-premise
        11.3.2. Web-based
        11.3.3. Others
        11.3.4. Cloud-based/Software-as-a-service (SaaS)
    11.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        11.4.1. Phase I
        11.4.2. Phase II
        11.4.3. Phase III
        11.4.4. Phase IV
    11.5. Market Value Forecast, by End-user, 2017-2031
        11.5.1. Pharmaceutical & Biotechnology Companies
        11.5.2. Medical Device Manufacturers
        11.5.3. Contract Research Organizations
        11.5.4. Others
    11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Solution Type
        11.7.2. By Delivery Mode
        11.7.3. By Clinical Trial Phase
        11.7.4. By End-user
        11.7.5. By Country/Sub-region
12. Europe eClinical Solutions Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Solution Type, 2017-2031
        12.2.1. Clinical Trial Management Systems
        12.2.2. Electronic Clinical Outcome Assessment
        12.2.3. Randomization & Trial Supply Management
        12.2.4. Electronic Data Capture & Clinical Data Management
        12.2.5. Electronic Trial Master Files
        12.2.6. Patient Recruitment
        12.2.7. Regulatory Information Management Systems
        12.2.8. Others
    12.3. Market Value Forecast, by Delivery Mode, 2017-2031
        12.3.1. Licensed Enterprise/On-premise
        12.3.2. Web-based
        12.3.3. Others
        12.3.4. Cloud-based/Software-as-a-service (SaaS)
    12.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        12.4.1. Phase I
        12.4.2. Phase II
        12.4.3. Phase III
        12.4.4. Phase IV
    12.5. Market Value Forecast, by End-user, 2017-2031
        12.5.1. Pharmaceutical & Biotechnology Companies
        12.5.2. Medical Device Manufacturers
        12.5.3. Contract Research Organizations
        12.5.4. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Solution Type
        12.7.2. By Delivery Mode
        12.7.3. By Clinical Trial Phase
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific eClinical Solutions Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Solution Type, 2017-2031
        13.2.1. Clinical Trial Management Systems
        13.2.2. Electronic Clinical Outcome Assessment
        13.2.3. Randomization & Trial Supply Management
        13.2.4. Electronic Data Capture & Clinical Data Management
        13.2.5. Electronic Trial Master Files
        13.2.6. Patient Recruitment
        13.2.7. Regulatory Information Management Systems
        13.2.8. Others
    13.3. Market Value Forecast, by Delivery Mode, 2017-2031
        13.3.1. Licensed Enterprise/On-premise
        13.3.2. Web-based
        13.3.3. Others
        13.3.4. Cloud-based/Software-as-a-service (SaaS)
    13.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        13.4.1. Phase I
        13.4.2. Phase II
        13.4.3. Phase III
        13.4.4. Phase IV
    13.5. Market Value Forecast, by End-user, 2017-2031
        13.5.1. Pharmaceutical & Biotechnology Companies
        13.5.2. Medical Device Manufacturers
        13.5.3. Contract Research Organizations
        13.5.4. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Solution Type
        13.7.2. By Delivery Mode
        13.7.3. By Clinical Trial Phase
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America eClinical Solutions Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Solution Type, 2017-2031
        14.2.1. Clinical Trial Management Systems
        14.2.2. Electronic Clinical Outcome Assessment
        14.2.3. Randomization & Trial Supply Management
        14.2.4. Electronic Data Capture & Clinical Data Management
        14.2.5. Electronic Trial Master Files
        14.2.6. Patient Recruitment
        14.2.7. Regulatory Information Management Systems
        14.2.8. Others
    14.3. Market Value Forecast, by Delivery Mode, 2017-2031
        14.3.1. Licensed Enterprise/On-premise
        14.3.2. Web-based
        14.3.3. Others
        14.3.4. Cloud-based/Software-as-a-service (SaaS)
    14.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        14.4.1. Phase I
        14.4.2. Phase II
        14.4.3. Phase III
        14.4.4. Phase IV
    14.5. Market Value Forecast, by End-user, 2017-2031
        14.5.1. Pharmaceutical & Biotechnology Companies
        14.5.2. Medical Device Manufacturers
        14.5.3. Contract Research Organizations
        14.5.4. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Solution Type
        14.7.2. By Delivery Mode
        14.7.3. By Clinical Trial Phase
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa eClinical Solutions Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Solution Type, 2017-2031
        15.2.1. Clinical Trial Management Systems
        15.2.2. Electronic Clinical Outcome Assessment
        15.2.3. Randomization & Trial Supply Management
        15.2.4. Electronic Data Capture & Clinical Data Management
        15.2.5. Electronic Trial Master Files
        15.2.6. Patient Recruitment
        15.2.7. Regulatory Information Management Systems
        15.2.8. Others
    15.3. Market Value Forecast, by Delivery Mode, 2017-2031
        15.3.1. Licensed Enterprise/On-premise
        15.3.2. Web-based
        15.3.3. Others
        15.3.4. Cloud-based/Software-as-a-service (SaaS)
    15.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        15.4.1. Phase I
        15.4.2. Phase II
        15.4.3. Phase III
        15.4.4. Phase IV
    15.5. Market Value Forecast, by End-user, 2017-2031
        15.5.1. Pharmaceutical & Biotechnology Companies
        15.5.2. Medical Device Manufacturers
        15.5.3. Contract Research Organizations
        15.5.4. Others
    15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Solution Type
        15.7.2. By Delivery Mode
        15.7.3. By Clinical Trial Phase
        15.7.4. By End-user
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. ArisGlobal LLC
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Clario
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. eClinical Solutions LLC
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Evidation Health, Inc.
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Florence Healthcare
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Advarra, Inc.
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Dassault Systèmes S.E. (Medidata)
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Medrio, Inc.
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Oracle Corporation
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Parexel Corporation
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. Signant Health
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview
        16.3.12. Veeva Systems Inc.
            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.12.2. Product Portfolio
            16.3.12.3. Financial Overview
            16.3.12.4. SWOT Analysis
            16.3.12.5. Strategic Overview
        16.3.13. Viedoc Technologies
            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.13.2. Product Portfolio
            16.3.13.3. Financial Overview
            16.3.13.4. SWOT Analysis
            16.3.13.5. Strategic Overview
        16.3.14. MedNet Solutions
            16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.14.2. Product Portfolio
            16.3.14.3. Financial Overview
            16.3.14.4. SWOT Analysis
            16.3.14.5. Strategic Overview
        16.3.15. Anju Software, Inc.
            16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.15.2. Product Portfolio
            16.3.15.3. Financial Overview
            16.3.15.4. SWOT Analysis
            16.3.15.5. Strategic Overview
        16.3.16. Other Prominent Players
            16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.16.2. Product Portfolio
            16.3.16.3. Financial Overview
            16.3.16.4. SWOT Analysis
            16.3.16.5. Strategic Overview

　

ページTOPに戻る


　

Summary

eClinical Solutions Market – Scope of Report
TMR’s report on the global eClinical solutions market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global eClinical solutions market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global eClinical solutions market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the eClinical solutions market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global eClinical solutions market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global eClinical solutions market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global eClinical solutions market.

The report delves into the competitive landscape of the global eClinical solutions market. Key players operating in the global eClinical solutions market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global eClinical solutions market profiled in this report.

Key Questions Answered in Global eClinical Solutions Market Report
• What is the sales/revenue generated by eClinical solutions across all regions during the forecast period?
• What are the opportunities in the global eClinical solutions market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

eClinical Solutions Market – Research Objectives and Research Approach
The comprehensive report on the global eClinical solutions market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global eClinical solutions market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global eClinical solutions market.



ページTOPに戻る


Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global eClinical Solutions Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global eClinical Solutions Market Analysis and Forecast, 2017-2031
        4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
    5.1. Technological Advancements
    5.2. Regulatory Scenario, by Region
    5.3. Value Chain Analysis
    5.4. COVID-19 impact on the Industry
6. Global eClinical Solutions Market Analysis and Forecast, by Solution Type
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Solution Type, 2017-2031
        6.3.1. Clinical Trial Management Systems
        6.3.2. Electronic Clinical Outcome Assessment
        6.3.3. Randomization & Trial Supply Management
        6.3.4. Electronic Data Capture & Clinical Data Management
        6.3.5. Electronic Trial Master Files
        6.3.6. Patient Recruitment
        6.3.7. Regulatory Information Management Systems
        6.3.8. Others
    6.4. Market Attractiveness Analysis, by Solution Type
7. Global eClinical Solutions Market Analysis and Forecast, by Delivery Mode
    7.1. Introduction & Definition
    7.2. Key Findings/Developments
    7.3. Market Value Forecast, by Delivery Mode, 2017-2031
        7.3.1. Licensed Enterprise/On-premise
        7.3.2. Web-based
        7.3.3. Others
        7.3.4. Cloud-based/Software-as-a-service (SaaS)
    7.4. Market Attractiveness Analysis, by Delivery Mode
8. Global eClinical Solutions Market Analysis and Forecasts, by Clinical Trial Phase
    8.1. Introduction & Definition
    8.2. Key Findings/Developments
    8.3. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        8.3.1. Phase I
        8.3.2. Phase II
        8.3.3. Phase III
        8.3.4. Phase IV
    8.4. Market Attractiveness Analysis, by Clinical Trial Phase
9. Global eClinical Solutions Market Analysis and Forecast, by End-user
    9.1. Introduction & Definition
    9.2. Key Findings/Developments
    9.3. Market Value Forecast, by End-user, 2017-2031
        9.3.1. Pharmaceutical & Biotechnology Companies
        9.3.2. Medical Device Manufacturers
        9.3.3. Contract Research Organizations
        9.3.4. Others
    9.4. Market Attractiveness Analysis, by End-user
10. Global eClinical Solutions Market Analysis and Forecast, by Region
    10.1. Key Findings
    10.2. Market Value Forecast, by Region, 2017-2031
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness By Country/Region
11. North America eClinical Solutions Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Solution Type, 2017-2031
        11.2.1. Clinical Trial Management Systems
        11.2.2. Electronic Clinical Outcome Assessment
        11.2.3. Randomization & Trial Supply Management
        11.2.4. Electronic Data Capture & Clinical Data Management
        11.2.5. Electronic Trial Master Files
        11.2.6. Patient Recruitment
        11.2.7. Regulatory Information Management Systems
        11.2.8. Others
    11.3. Market Value Forecast, by Delivery Mode, 2017-2031
        11.3.1. Licensed Enterprise/On-premise
        11.3.2. Web-based
        11.3.3. Others
        11.3.4. Cloud-based/Software-as-a-service (SaaS)
    11.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        11.4.1. Phase I
        11.4.2. Phase II
        11.4.3. Phase III
        11.4.4. Phase IV
    11.5. Market Value Forecast, by End-user, 2017-2031
        11.5.1. Pharmaceutical & Biotechnology Companies
        11.5.2. Medical Device Manufacturers
        11.5.3. Contract Research Organizations
        11.5.4. Others
    11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Solution Type
        11.7.2. By Delivery Mode
        11.7.3. By Clinical Trial Phase
        11.7.4. By End-user
        11.7.5. By Country/Sub-region
12. Europe eClinical Solutions Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Solution Type, 2017-2031
        12.2.1. Clinical Trial Management Systems
        12.2.2. Electronic Clinical Outcome Assessment
        12.2.3. Randomization & Trial Supply Management
        12.2.4. Electronic Data Capture & Clinical Data Management
        12.2.5. Electronic Trial Master Files
        12.2.6. Patient Recruitment
        12.2.7. Regulatory Information Management Systems
        12.2.8. Others
    12.3. Market Value Forecast, by Delivery Mode, 2017-2031
        12.3.1. Licensed Enterprise/On-premise
        12.3.2. Web-based
        12.3.3. Others
        12.3.4. Cloud-based/Software-as-a-service (SaaS)
    12.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        12.4.1. Phase I
        12.4.2. Phase II
        12.4.3. Phase III
        12.4.4. Phase IV
    12.5. Market Value Forecast, by End-user, 2017-2031
        12.5.1. Pharmaceutical & Biotechnology Companies
        12.5.2. Medical Device Manufacturers
        12.5.3. Contract Research Organizations
        12.5.4. Others
    12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Solution Type
        12.7.2. By Delivery Mode
        12.7.3. By Clinical Trial Phase
        12.7.4. By End-user
        12.7.5. By Country/Sub-region
13. Asia Pacific eClinical Solutions Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Solution Type, 2017-2031
        13.2.1. Clinical Trial Management Systems
        13.2.2. Electronic Clinical Outcome Assessment
        13.2.3. Randomization & Trial Supply Management
        13.2.4. Electronic Data Capture & Clinical Data Management
        13.2.5. Electronic Trial Master Files
        13.2.6. Patient Recruitment
        13.2.7. Regulatory Information Management Systems
        13.2.8. Others
    13.3. Market Value Forecast, by Delivery Mode, 2017-2031
        13.3.1. Licensed Enterprise/On-premise
        13.3.2. Web-based
        13.3.3. Others
        13.3.4. Cloud-based/Software-as-a-service (SaaS)
    13.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        13.4.1. Phase I
        13.4.2. Phase II
        13.4.3. Phase III
        13.4.4. Phase IV
    13.5. Market Value Forecast, by End-user, 2017-2031
        13.5.1. Pharmaceutical & Biotechnology Companies
        13.5.2. Medical Device Manufacturers
        13.5.3. Contract Research Organizations
        13.5.4. Others
    13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        13.6.1. China
        13.6.2. Japan
        13.6.3. India
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Solution Type
        13.7.2. By Delivery Mode
        13.7.3. By Clinical Trial Phase
        13.7.4. By End-user
        13.7.5. By Country/Sub-region
14. Latin America eClinical Solutions Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Solution Type, 2017-2031
        14.2.1. Clinical Trial Management Systems
        14.2.2. Electronic Clinical Outcome Assessment
        14.2.3. Randomization & Trial Supply Management
        14.2.4. Electronic Data Capture & Clinical Data Management
        14.2.5. Electronic Trial Master Files
        14.2.6. Patient Recruitment
        14.2.7. Regulatory Information Management Systems
        14.2.8. Others
    14.3. Market Value Forecast, by Delivery Mode, 2017-2031
        14.3.1. Licensed Enterprise/On-premise
        14.3.2. Web-based
        14.3.3. Others
        14.3.4. Cloud-based/Software-as-a-service (SaaS)
    14.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        14.4.1. Phase I
        14.4.2. Phase II
        14.4.3. Phase III
        14.4.4. Phase IV
    14.5. Market Value Forecast, by End-user, 2017-2031
        14.5.1. Pharmaceutical & Biotechnology Companies
        14.5.2. Medical Device Manufacturers
        14.5.3. Contract Research Organizations
        14.5.4. Others
    14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Solution Type
        14.7.2. By Delivery Mode
        14.7.3. By Clinical Trial Phase
        14.7.4. By End-user
        14.7.5. By Country/Sub-region
15. Middle East & Africa eClinical Solutions Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast, by Solution Type, 2017-2031
        15.2.1. Clinical Trial Management Systems
        15.2.2. Electronic Clinical Outcome Assessment
        15.2.3. Randomization & Trial Supply Management
        15.2.4. Electronic Data Capture & Clinical Data Management
        15.2.5. Electronic Trial Master Files
        15.2.6. Patient Recruitment
        15.2.7. Regulatory Information Management Systems
        15.2.8. Others
    15.3. Market Value Forecast, by Delivery Mode, 2017-2031
        15.3.1. Licensed Enterprise/On-premise
        15.3.2. Web-based
        15.3.3. Others
        15.3.4. Cloud-based/Software-as-a-service (SaaS)
    15.4. Market Value Forecast, by Clinical Trial Phase, 2017-2031
        15.4.1. Phase I
        15.4.2. Phase II
        15.4.3. Phase III
        15.4.4. Phase IV
    15.5. Market Value Forecast, by End-user, 2017-2031
        15.5.1. Pharmaceutical & Biotechnology Companies
        15.5.2. Medical Device Manufacturers
        15.5.3. Contract Research Organizations
        15.5.4. Others
    15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
        15.6.1. GCC Countries
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Solution Type
        15.7.2. By Delivery Mode
        15.7.3. By Clinical Trial Phase
        15.7.4. By End-user
        15.7.5. By Country/Sub-region
16. Competition Landscape
    16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
    16.2. Market Share Analysis, by Company (2022)
    16.3. Company Profiles
        16.3.1. ArisGlobal LLC
            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.1.2. Product Portfolio
            16.3.1.3. Financial Overview
            16.3.1.4. SWOT Analysis
            16.3.1.5. Strategic Overview
        16.3.2. Clario
            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.2.2. Product Portfolio
            16.3.2.3. Financial Overview
            16.3.2.4. SWOT Analysis
            16.3.2.5. Strategic Overview
        16.3.3. eClinical Solutions LLC
            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.3.2. Product Portfolio
            16.3.3.3. Financial Overview
            16.3.3.4. SWOT Analysis
            16.3.3.5. Strategic Overview
        16.3.4. Evidation Health, Inc.
            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.4.2. Product Portfolio
            16.3.4.3. Financial Overview
            16.3.4.4. SWOT Analysis
            16.3.4.5. Strategic Overview
        16.3.5. Florence Healthcare
            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.5.2. Product Portfolio
            16.3.5.3. Financial Overview
            16.3.5.4. SWOT Analysis
            16.3.5.5. Strategic Overview
        16.3.6. Advarra, Inc.
            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.6.2. Product Portfolio
            16.3.6.3. Financial Overview
            16.3.6.4. SWOT Analysis
            16.3.6.5. Strategic Overview
        16.3.7. Dassault Systèmes S.E. (Medidata)
            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.7.2. Product Portfolio
            16.3.7.3. Financial Overview
            16.3.7.4. SWOT Analysis
            16.3.7.5. Strategic Overview
        16.3.8. Medrio, Inc.
            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.8.2. Product Portfolio
            16.3.8.3. Financial Overview
            16.3.8.4. SWOT Analysis
            16.3.8.5. Strategic Overview
        16.3.9. Oracle Corporation
            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.9.2. Product Portfolio
            16.3.9.3. Financial Overview
            16.3.9.4. SWOT Analysis
            16.3.9.5. Strategic Overview
        16.3.10. Parexel Corporation
            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.10.2. Product Portfolio
            16.3.10.3. Financial Overview
            16.3.10.4. SWOT Analysis
            16.3.10.5. Strategic Overview
        16.3.11. Signant Health
            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.11.2. Product Portfolio
            16.3.11.3. Financial Overview
            16.3.11.4. SWOT Analysis
            16.3.11.5. Strategic Overview
        16.3.12. Veeva Systems Inc.
            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.12.2. Product Portfolio
            16.3.12.3. Financial Overview
            16.3.12.4. SWOT Analysis
            16.3.12.5. Strategic Overview
        16.3.13. Viedoc Technologies
            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.13.2. Product Portfolio
            16.3.13.3. Financial Overview
            16.3.13.4. SWOT Analysis
            16.3.13.5. Strategic Overview
        16.3.14. MedNet Solutions
            16.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.14.2. Product Portfolio
            16.3.14.3. Financial Overview
            16.3.14.4. SWOT Analysis
            16.3.14.5. Strategic Overview
        16.3.15. Anju Software, Inc.
            16.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.15.2. Product Portfolio
            16.3.15.3. Financial Overview
            16.3.15.4. SWOT Analysis
            16.3.15.5. Strategic Overview
        16.3.16. Other Prominent Players
            16.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
            16.3.16.2. Product Portfolio
            16.3.16.3. Financial Overview
            16.3.16.4. SWOT Analysis
            16.3.16.5. Strategic Overview

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

Transparency Market Research社の医療分野での最新刊レポート

本レポートと同じKEY WORD（clinical trial）の最新刊レポート


よくあるご質問


Transparency Market Research社はどのような調査会社ですか?


トレンスペアレンシーマーケットリサーチ（Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20　10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.